Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - PROGENICS PHARMACEUTICALS INCex_174848.htm
EX-32.1 - EXHIBIT 32.1 - PROGENICS PHARMACEUTICALS INCex_174847.htm
EX-31.2 - EXHIBIT 31.2 - PROGENICS PHARMACEUTICALS INCex_174846.htm
EX-31.1 - EXHIBIT 31.1 - PROGENICS PHARMACEUTICALS INCex_174845.htm
EX-23.1 - EXHIBIT 23.1 - PROGENICS PHARMACEUTICALS INCex_174844.htm
EX-10.55 - EXHIBIT 10.55 - PROGENICS PHARMACEUTICALS INCex_176151.htm
EX-10.54 - EXHIBIT 10.54 - PROGENICS PHARMACEUTICALS INCex_174842.htm
EX-10.51 - EXHIBIT 10.51 - PROGENICS PHARMACEUTICALS INCex_174841.htm
EX-10.50 - EXHIBIT 10.50 - PROGENICS PHARMACEUTICALS INCex_174840.htm
EX-10.48 - EXHIBIT 10.48 - PROGENICS PHARMACEUTICALS INCex_174839.htm
EX-4.2 - EXHIBIT 4.2 - PROGENICS PHARMACEUTICALS INCex_174838.htm
10-K - FORM 10-K - PROGENICS PHARMACEUTICALS INCprog20191231_10k.htm

Exhibit 21.1

 

 

Progenics Pharmaceuticals, Inc.

Subsidiaries

 

 

Name

 

Jurisdiction of Incorporation

     

Excelsior Life Sciences Ireland Limited

 

Ireland

Molecular Insight Pharmaceuticals, Inc.

 

Delaware

Molecular Insight Limited*

 

England and Wales

Progenics Life Sciences Limited

 

England and Wales

Progenics Pharmaceuticals Nevada, Inc.

 

Nevada

PSMA Development Company LLC

 

Delaware

EXINI Diagnostics AB

 

Sweden

MNTX Royalties Sub LLC

 

Delaware

     

* Subsidiary of Molecular Insight Pharmaceuticals, Inc.